Boston Scientific Revenue and Competitors
Estimated Revenue & Valuation
- Boston Scientific's estimated annual revenue is currently $68.5M per year.
- Boston Scientific's estimated revenue per employee is $251,000
Employee Data
- Boston Scientific has 273 Employees.
Boston Scientific's People
Name | Title | Email/Phone |
---|
Boston Scientific Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Boston Scientific?
Boston Scientific is a manufacturer of medical devices, including Transcatheter Aortic Heart Valve Replacement (TAVR) and other key technologies in the structural heart space.
keywords:N/AN/A
Total Funding
273
Number of Employees
$68.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Boston Scientific News
2022-04-20 - ReWalk Robotics appoints Fresenius, Boston Scientific ...
... developer having begun his career at McKinsey and Company before joining Boston Scientific as its director of new business development.
2022-04-20 - ReWalk appoints Fresenius, former Boston Scientific ...
ReWalk appoints Fresenius, former Boston Scientific executive to its board. Photo | Courtesy of ReWalk Robotics, Ltd. ReWalk's ReBoot device...
2022-04-19 - NACD New England Honors Boston Scientific, A.D. ...
NACD New England Honors Boston Scientific, A.D. Makepeace, Rapid7 CEO Corey Thomas, Bennie Wiley, and Jack F. O'Brien at Director of the Year...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $125.8M | 671 | 0% | N/A |
#2 | $158.7M | 872 | N/A | N/A |
#3 | $278.6M | 990 | N/A | N/A |
#4 | $452.1M | 2227 | N/A | N/A |
#5 | $2550M | 3905 | -5% | $208.6M |